Pediatric Drug Development

Discover the essential resource for pediatric drug development with the Pediatric Drug Development, Second Edition by Andrew E. Mulberg. Published by John Wiley and Sons Ltd in 2013, this comprehensive guide spans 624 pages, providing an in-depth exploration of the latest regulatory initiatives across the EU, US, and the rest of the world. This edition highlights significant advancements in biomarkers, surrogate endpoints, and developmental pharmacology, ensuring that healthcare professionals are equipped with the knowledge needed to enhance access to safe and effective medicines for children. Whether you are involved in clinical trials or drug evaluation, this book is a vital addition to your library, offering ethical standards and innovative methods in pediatric drug development. Stay informed and improve your practice with this authoritative text.